Perspective Therapeutics Inc (CATX)
3.00
-3.17
(-51.38%)
USD |
NYAM |
Nov 21, 16:00
2.99
-0.01
(-0.33%)
After-Hours: 20:00
Perspective Therapeutics Enterprise Value: -63.40M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -63.40M |
| November 20, 2024 | 150.86M |
| November 19, 2024 | 192.09M |
| November 18, 2024 | 204.25M |
| November 15, 2024 | 266.43M |
| November 14, 2024 | 336.72M |
| November 13, 2024 | 404.99M |
| November 12, 2024 | 455.00M |
| November 11, 2024 | 483.39M |
| November 08, 2024 | 494.20M |
| November 07, 2024 | 530.02M |
| November 06, 2024 | 567.57M |
| November 05, 2024 | 567.57M |
| November 04, 2024 | 557.43M |
| November 01, 2024 | 550.68M |
| October 31, 2024 | 531.76M |
| October 30, 2024 | 508.79M |
| October 29, 2024 | 535.81M |
| October 28, 2024 | 538.51M |
| October 25, 2024 | 512.84M |
| October 24, 2024 | 537.16M |
| October 23, 2024 | 523.65M |
| October 22, 2024 | 570.95M |
| October 21, 2024 | 591.89M |
| October 18, 2024 | 588.51M |
| Date | Value |
|---|---|
| October 17, 2024 | 554.73M |
| October 16, 2024 | 612.16M |
| October 15, 2024 | 582.43M |
| October 14, 2024 | 564.19M |
| October 11, 2024 | 589.19M |
| October 10, 2024 | 629.05M |
| October 09, 2024 | 618.91M |
| October 08, 2024 | 623.64M |
| October 07, 2024 | 620.94M |
| October 04, 2024 | 635.81M |
| October 03, 2024 | 626.35M |
| October 02, 2024 | 626.35M |
| October 01, 2024 | 587.16M |
| September 30, 2024 | 635.81M |
| September 27, 2024 | 556.40M |
| September 26, 2024 | 535.50M |
| September 25, 2024 | 528.76M |
| September 24, 2024 | 536.85M |
| September 23, 2024 | 533.48M |
| September 20, 2024 | 600.90M |
| September 19, 2024 | 617.09M |
| September 18, 2024 | 609.00M |
| September 17, 2024 | 606.97M |
| September 16, 2024 | 593.49M |
| September 13, 2024 | 726.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-63.40M
Minimum
Nov 21 2024
916.89M
Maximum
May 14 2024
140.04M
Average
45.67M
Median
Enterprise Value Benchmarks
| Plus Therapeutics Inc | 5.580M |
| Retractable Technologies Inc | -17.27M |
| InfuSystems Holdings Inc | 224.07M |
| Xtant Medical Holdings Inc | 85.83M |
| Catheter Precision Inc | 3.891M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.12M |
| Total Expenses (Quarterly) | 18.63M |
| EPS Diluted (Quarterly) | -0.21 |
| Earnings Yield | -48.67% |
| Normalized Earnings Yield | -20.00 |